NDC 61314-325 – Adalimumab
Adalimumab 80 mg/.8mL · Injection, Solution · Subcutaneous
Product NDC61314-325
Product details
- Brand name
- Adalimumab
- Generic name
- Adalimumab-adaz
- Labeler
- Sandoz Inc
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761071
- Marketed since
- January 6, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Tumor Necrosis Factor Blocker
Active ingredients
- Adalimumab 80 mg/.8mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61314-325-20 | 2 SYRINGE in 1 CARTON (61314-325-20) / .8 mL in 1 SYRINGE | Jan 6, 2025 |
Other Adalimumab products
- 61314-327 Adalimumab 40 mg/.4mL · Injection, Solution · Sandoz Inc
- 61314-332 Adalimumab 20 mg/.2mL · Injection, Solution · Sandoz Inc
- 61314-391 Adalimumab 10 mg/.1mL · Injection, Solution · Sandoz Inc
- 83257-020 · Kit · Biocon Biologics Inc
- 83257-021 · Kit · Biocon Biologics Inc
- 83257-022 · Kit · Biocon Biologics Inc
- 72606-022 · Kit · CELLTRION USA, Inc.
- 72606-040 · Kit · CELLTRION USA, Inc.
- 72606-041 · Kit · CELLTRION USA, Inc.